A Phase I, Open-label, Randomized, 3-way Crossover Trial in Healthy Subjects to Investigate the Pharmacokinetic Interaction Between TMC435 and Escitalopram at Steady-state.
Phase of Trial: Phase I
Latest Information Update: 08 Apr 2013
At a glance
- Drugs Simeprevir (Primary) ; Escitalopram
- Indications Depressive disorders; Generalised anxiety disorder; Hepatitis C; Obsessive-compulsive disorders; Panic disorder; Premenstrual dysphoric disorder; Social phobia
- Focus Pharmacokinetics
- Sponsors Janssen R&D Ireland
- 10 Jun 2017 Biomarkers information updated
- 20 Mar 2012 Additional location (Ireland) added as reported by ClinicalTrials.gov.
- 20 Mar 2012 Actual end date (Sep 2010) added as reported by ClinicalTrials.gov.